[go: up one dir, main page]

HRP20080438T3 - Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases - Google Patents

Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases

Info

Publication number
HRP20080438T3
HRP20080438T3 HR20080438T HRP20080438T HRP20080438T3 HR P20080438 T3 HRP20080438 T3 HR P20080438T3 HR 20080438 T HR20080438 T HR 20080438T HR P20080438 T HRP20080438 T HR P20080438T HR P20080438 T3 HRP20080438 T3 HR P20080438T3
Authority
HR
Croatia
Prior art keywords
octenidine
used against
against inflammatory
containing lozenges
inflammatory oral
Prior art date
Application number
HR20080438T
Other languages
English (en)
Croatian (hr)
Inventor
Miething Holger
Original Assignee
Divapharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Divapharma Gmbh filed Critical Divapharma Gmbh
Publication of HRP20080438T3 publication Critical patent/HRP20080438T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20080438T 2004-10-12 2005-08-19 Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases HRP20080438T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004049798 2004-10-12
DE102004052308A DE102004052308B4 (de) 2004-10-12 2004-10-28 Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums
PCT/EP2005/008973 WO2006039961A1 (fr) 2004-10-12 2005-08-19 Comprimes a sucer contenant de l'octenidine, contre les maladies inflammatoires de la cavite buccopharyngee

Publications (1)

Publication Number Publication Date
HRP20080438T3 true HRP20080438T3 (en) 2008-10-31

Family

ID=35149087

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080438T HRP20080438T3 (en) 2004-10-12 2005-08-19 Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases

Country Status (14)

Country Link
EP (1) EP1799186B1 (fr)
CN (1) CN101052373B (fr)
AT (1) ATE398441T1 (fr)
DE (2) DE102004052308B4 (fr)
EA (1) EA011991B1 (fr)
ES (1) ES2309790T3 (fr)
GE (1) GEP20094809B (fr)
HR (1) HRP20080438T3 (fr)
NO (1) NO20071795L (fr)
PL (1) PL1799186T3 (fr)
RS (1) RS50593B (fr)
SI (1) SI1799186T1 (fr)
UA (1) UA83320C2 (fr)
WO (1) WO2006039961A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090110716A1 (en) 2007-10-31 2009-04-30 Frank Bunick Orally disintegrative dosage form
ES2400210T3 (es) 2008-10-02 2013-04-08 Mylan Inc. Método para preparar un laminado de adhesivo multicapa
EP2201951A1 (fr) * 2008-11-14 2010-06-30 Ahmet Melih Aydinoglu Composition d'octénidine
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8871263B2 (en) 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
PL3284459T3 (pl) 2011-04-29 2021-06-28 Moberg Pharma Ab Kompozycje farmaceutyczne zawierające środek miejscowo znieczulający, taki jak bupiwakaina, do podawania miejscowego do jamy ustnej lub gardła
DE102012000976A1 (de) * 2012-01-20 2013-07-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Behandlung
DE102012007212A1 (de) * 2012-04-11 2013-10-17 Merz Pharma Gmbh & Co. Kgaa Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
DE202013000446U1 (de) * 2012-10-04 2013-10-07 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung, insbesondere pharmazeutische Zusammensetzung, insbesondere zur Verabreichung bei Heiserkeit und Halsschmerzen
RU2712267C2 (ru) 2014-01-10 2020-01-28 Джонсон энд Джонсон Консьюмер Инк. Способ изготовления таблеток с использованием радиочастотного излучения и частиц с поглощающим покрытием
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US12295923B2 (en) 2018-12-27 2025-05-13 Solventum Intellectual Properties Company Antimicrobial compositions with 1,2-alkanediols
AU2024210182A1 (en) 2023-01-16 2025-07-10 Universidad Del País Vasco/Euskal Herriko Unibertsitatea Coating composition for the treatment or prevention of periimplantitis and preparation method thereof
WO2024179785A1 (fr) * 2023-03-02 2024-09-06 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Composition contenant de l'octénidine pour un traitement antiviral

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210386A (en) * 1983-12-09 1987-11-27 Sterling Drug Inc Saccharine salts and dentrifice compositions
WO1987005501A1 (fr) * 1986-03-17 1987-09-24 Oral Research Laboratories, Inc. Traitement des surfaces dentaires a l'aide d'agents retardant la plaque
GB9204410D0 (en) * 1992-02-29 1992-04-15 Smithkline Beecham Plc Method of treatment
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
DE10026716A1 (de) * 2000-05-30 2001-12-13 Ferton Holding Sa Prophylaktische Mundspüllösung
CN1287803C (zh) * 2000-06-30 2006-12-06 宝洁公司 促进全身健康的局部口腔组合物及其应用
DE10205883A1 (de) * 2002-02-13 2003-08-21 Schuelke & Mayr Gmbh Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen

Also Published As

Publication number Publication date
DE502005004475D1 (de) 2008-07-31
GEP20094809B (en) 2009-10-26
DE102004052308B4 (de) 2013-04-04
RS50593B (sr) 2010-05-07
NO20071795L (no) 2007-07-06
DE102004052308A1 (de) 2006-04-13
ES2309790T3 (es) 2008-12-16
UA83320C2 (ru) 2008-06-25
EP1799186B1 (fr) 2008-06-18
ATE398441T1 (de) 2008-07-15
CN101052373A (zh) 2007-10-10
CN101052373B (zh) 2010-06-16
EP1799186A1 (fr) 2007-06-27
EA200700777A1 (ru) 2007-10-26
PL1799186T3 (pl) 2008-11-28
EA011991B1 (ru) 2009-06-30
SI1799186T1 (sl) 2008-10-31
HK1108835A1 (en) 2008-05-23
WO2006039961A1 (fr) 2006-04-20

Similar Documents

Publication Publication Date Title
HRP20080438T3 (en) Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases
DK1827363T3 (da) Antibakteriel og antiinflammatorisk oral plejesammensætning
ITFI20050031A1 (it) Una composizione farmaceutica atta a prevenire l'invecchiamento e l'insorgere di malattie vascolari,neoplastiche,cutanee e dell'apparato pilifero
ATE540690T1 (de) Insulinkombinationen
AR109644A2 (es) Pradofloxacina y composición farmacéutica para el tratamiento sistémico de enfermedades bacterianas en la cavidad bucal
BRPI0513864A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades
WO2007093183A3 (fr) Procede de traitement de maladies inflammatoires
PT2336184E (pt) Administração de agentes para o tratamento da inflamação
NO20034549D0 (no) Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV
IS8229A (is) Notkun á rótigótíni við meðferð á þugnlyndi
DK1467724T3 (da) Farmaceutisk sammensætning med agomelatin til dispergering i mundhulen
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
ATE445389T1 (de) Liposomale glucocorticoide
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
WO2010044585A3 (fr) Composes de piperidine, composition pharmaceutique les contenant et utilisation associee
LU92202I2 (fr) Aflibercept
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
UA87841C2 (ru) Композиция, которая содержит амброксол, для местного применения
EP1594959A4 (fr) Methode therapeutique et compositions destinees a une administration topique
DE60330764D1 (de) Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
NO20070187L (no) Oralt desintegrerende farmasoytisk preparat omfattende risperidon
SE0202365D0 (sv) New formulation and use thereof
RS50523B (sr) Farmaceutska kompozicija koja sadrži cink-hijaluronat kompleks za lečenje multiple skleroze
MXPA01009032A (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso se la produccion de il-12.
EA200702274A1 (ru) Твёрдые кристаллические и аморфные формы (-)-галофената и способ их получения, фармацевтическая композиция на их основе и способ лечения